Gates Foundation Awards Opko $1M for TB MDx Development | GenomeWeb

NEW YORK (GenomeWeb News) – Opko Health has received a $1 million grant from the Bill and Melinda Gates Foundation for the development of a tuberculosis test, the company announced today.

The grant will support development of a test for distinguishing latent TB from active TB using Opko's molecular diagnostics technology. The Miami-based firm also leverages the technology to create blood-based tests for identifying biomarkers for diseases including neurodegenerative disorders and malignancies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.